Information  X 
Enter a valid email address

British Am. Tobacco (BATS)

  Print      Mail a friend       Annual reports

Monday 13 May, 2019

British Am. Tobacco

Director/PDMR Shareholding

RNS Number : 8632Y
British American Tobacco PLC
13 May 2019
 

British American Tobacco p.l.c.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Johan Vandermeulen

2

Reason for the notification

a)

Position/status

Regional Director, Europe and North Africa

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

British American Tobacco p.l.c.

b)

LEI

213800FKA5MF17RJKT63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code


Ordinary shares of 25p each

 

GB0002875804

b)

Nature of the transaction

Acquisition of shares as a result of the reinvestment of dividend income under the British American Tobacco Dividend Reinvestment Plan.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£28.329107

2

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

2

 

£28.329107

e)

Date of the transaction

2019-05-08

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

Name of officer of issuer responsible for making notification: Sophie Kerr 

Date of notification: 13 May 2019

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZXLFFKEFZBBD

a d v e r t i s e m e n t